19 completed, 10 unknown, 7 terminated, 3 withdrawn. 40 Phase 2, 5 Phase 3, 4 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 40 | Completed 19, Unknown 10, Terminated 7, Withdrawn 3, Recruiting 1 |
| Phase 3 | 5 | Completed 2, Unknown 2, Terminated 1 |
| Phase 1 | 4 | Unknown 3, Terminated 1 |
Follow Convalescent plasma: new trials by email Literature Review of Convalescent plasma trials Research Report on Convalescent plasma
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Convalescent Plasma Therapy for Hospitalized Patients With COVID-19 Convalescent plasma, Standard of care - COVID-19, Convalescent Plasma | Phase 2 | Completed | Tânia Portella Costa | 38 | 2022-01-06 | 2023-11-29 |
| Reconvalescent Plasma/Camostat Mesylate Early in SARS-CoV-2 Q-PCR (COVID-19) Positive High-risk Individuals Convalescent plasma, Camostat Mesilate, Placebo for Camostat Mesilate - Corona Virus Infection, SARS-CoV-2 Infection | Phase 2 | Completed | Heinrich-Heine University, Duesseldorf | 22 | 2021-01-08 | 2022-02-10 |
| Convalescent Plasma for Treating Patients With COVID-19 Pneumonia Without Indication of Ventilatory Support Convalescent plasma - COVID-19 | Phase 2 | Unknown | D'Or Institute for Research and Education | 60 | 2020-12-11 | 2021-08-06 |
| Convalescent Plasma as Treatment for Subjects With Early COVID-19 Infection Convalescent Plasma, Best Supportive Care - COVID-19 | Phase 2 | Terminated | Hackensack Meridian Health | 21 | 2020-11-06 | 2023-10-10 |
| Administration of Anti-SARS-CoV-2 Convalescent Plasma in Hospitalized, Non-ICU Patients With COVID-19 anti-SARS-CoV-2 plasma, Placebo - COVID-19 | Phase 2 | Withdrawn | Kashif Khan | 2020-10-01 | 2020-10-22 | |
| PERUCONPLASMA: Evaluating the Use of Convalescent Plasma as Management of COVID-19 Convalescent plasma - COVID-19 | Phase 2 | Completed | Universidad Peruana Cayetano Heredia | 100 | 2020-09-21 | 2021-10-28 |
| Efficacy of CONvalescent Plasma in Patients With COVID-19 Treated With Mechanical Ventilation Convalescent Plasma, Standard of Care - Covid19, Mechanical Ventilation Complication | Phase 2 | Completed | University of Liege | 475 | 2020-09-11 | 2024-10-29 |
| Safety and Efficacy of Convalescent Plasma Transfusion for Patients With COVID-19 convalescent plasma - COVID-19 | Phase 2 / Phase 3 | Unknown | Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran | 410 | 2020-08-25 | 2020-08-26 |
| Convalescent Plasma in the Early Treatment of High-Risk Patients With SARS-CoV-2 (COVID-19) Infection Convalescent Plasma - Covid19 | Phase 2 | Terminated | Joseph M. Flynn, D.O., MPH | 2 | 2020-08-14 | 2024-10-24 |
| Evaluating the Efficacy of Convalescent Plasma in Symptomatic Outpatients Infected With COVID-19 CCP - COVID-19 | Phase 2 | Completed | Metro Infectious Disease Consultants | 103 | 2020-08-12 | 2022-04-06 |
| COVID-19 Convalescent Plasma Therapy Convalescent plasma - SARS-CoV-2 Infection, COVID-19 Infection | Phase 2 / Phase 3 | Completed | Universidad Nacional de Asunción | 350 | 2020-08-10 | 2021-03-02 |
| Therapeutic Plasmapheresis in Critically Ill Adult Patients With COVID-19 Confirmed Diagnosis Convalescent plasma - COVID-19 | Phase 2 | Unknown | Fundación Cardiovascular de Colombia | 44 | 2020-08-01 | 2020-07-22 |
| Use of Convalescent Plasma for COVID-19 Convalescent Plasma - COVID | Phase 2 | Terminated | Northside Hospital, Inc. | 8 | 2020-07-14 | 2022-11-14 |
| Statistical and Epidemiological Study Based on the Use of Convalescent Plasma for the Management of Patients With COVID-19 Convalescent plasma - COVID-19 Pneumonia, Convalescent Plasma | Phase 1 / Phase 2 | Unknown | Universidad Autonoma de Coahuila | 15 | 2020-07-06 | 2020-07-07 |
| Treatment of Critically Ill Patients With Covid-19 With Convalescent Plasma Convalescent plasma - SARS-Associated Coronavirus, Covid19 | Phase 2 | Completed | Hospital de Infecciosas Francisco Javier Muniz | 134 | 2020-06-25 | 2021-08-25 |
| Study on the Safety and Efficacy of Convalescent Plasma in Patients With Severe COVID-19 Disease Biological - Severe COVID-19 Disease | Phase 2 | Completed | Hospital Central Militar | 150 | 2020-06-23 | 2021-05-10 |
| Assessment of the Effect of Convalescent Plasma Therapy in Patients With Life-threatening COVID19 Infection Convalescent Plasma, Standard of Care - COVID19 | Phase 1 / Phase 2 | Unknown | Cairo University | 67 | 2020-06-01 | 2020-09-29 |
| Treatment of Patients With COVID-19 With Convalescent Plasma convalescent plasma - COVID-19 | Phase 2 | Completed | University of Sao Paulo General Hospital | 129 | 2020-06-01 | 2022-05-19 |
| Convalescent Plasma Therapy in Severe COVID-19 Infection Convalescent plasma - Covid19, Convalescence | Phase 2 | Unknown | Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh | 20 | 2020-05-20 | 2020-05-27 |
| CONVALESCENT PLASMA FOR ILL PATIENTS BY COVID-19 convalescent plasma - COVID-19, SARS-CoV 2 | Phase 1 / Phase 2 | Unknown | Instituto de Seguridad y Servicios Sociales de los Trabajadores del Estado | 90 | 2020-05-20 | 2020-06-05 |
Showing 20 of 40. Sign in to see all of them.
COVID-19 (33) · Coronavirus Infections (10) · Severe Acute Respiratory Syndrome (4) · Convalescence (2) · Pneumonia (2) · Respiratory Distress Syndrome (2) · Critical Illness (1) · Hemorrhagic Fever, Ebola (1) · Hyaline Membrane Disease (1) · Respiratory Insufficiency (1) · Respiratory Tract Diseases (1)
Hackensack Meridian Health (2) · Azienda Ospedaliero, Universitaria Pisana (1) · Azienda Socio Sanitaria Territoriale di Mantova (1) · Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh (1) · Cairo University (1) · Centro de Hematología y Medicina Interna (1) · D'Or Institute for Research and Education (1) · Erasmus Medical Center (1) · Fundacin Biomedica Galicia Sur (1) · Fundación Cardiovascular de Colombia (1) · Heinrich-Heine University, Duesseldorf (1) · Henry Ford Health System (1) · Hospital Central Militar (1) · Hospital de Infecciosas Francisco Javier Muniz (1) · Institute of Tropical Medicine, Belgium (1)
United States (13) · Mexico (5) · Brazil (3) · Belgium (2) · Italy (2) · Argentina (1) · Bangladesh (1) · Colombia (1) · Egypt (1) · Germany (1) · Guinea (1) · India (1) · Indonesia (1) · Netherlands (1) · Paraguay (1)
Michele L Donato, MD (2) · Andri MT Lubis, MD, PhD (1) · Angelica Jimenez de Samudio, MD,MSc (1) · Bart Rijnders, MD, PhD (1) · Carlos A Gonzalez, MD (1) · Carmen G Torres, MD (1) · Eduardo M Rego, MD, PhD (1) · Elliott Bennett-Guerrero, MD (1) · Fiorella Krapp Lopez, MD, MSc (1) · Francesco Menichetti (1) · Geert Meyfroidt, MD, PhD (1) · Geneva Tatem, MD (1) · Johan van Griensven, MD (1) · Joseph M Flynn, DO, MPH (1)
PMID 34013969, PMID 36734509, PMID 37162745, PMID 33044747, PMID 32219428, PMID 11023960, PMID 20370679, PMID 25457751, PMID 26618098, PMID 26735992, PMID 26768570, PMID 27959686, PMID 32125452, PMID 32779705, PMID 32883593, PMID 32951151, PMID 33106167, PMID 33246499, PMID 33287790, PMID 33585799, PMID 33870923, PMID 34001174, PMID 34001215, PMID 34901997, PMID 35308034, PMID 37889107, PMID 3898484, PMID 39383382, PMID 39432177, PMID 41788496